Aetna Inc. (NYSE:AET) Rating Lowered to Neutral at Cantor Fitzgerald

Aetna Inc. (NYSE:AET) was downgraded by research analysts at Cantor Fitzgerald from an “overweight” rating to a “neutral” rating in a note issued to investors on Thursday, October 26th, Marketbeat.com reports.

A number of other analysts also recently commented on the company. Zacks Investment Research raised Aetna from a “hold” rating to a “strong-buy” rating and set a $184.00 price target for the company in a research report on Wednesday, October 25th. BMO Capital Markets initiated coverage on Aetna in a research report on Monday, October 16th. They issued a “market perform” rating and a $175.00 target price for the company. Jefferies Group LLC lifted their price target on Aetna from $163.00 to $165.00 and gave the company a “hold” rating in a research report on Friday, October 13th. Argus reissued a “buy” rating and set a $185.00 price objective (up previously from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. Finally, Morgan Stanley lifted their price target on Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a research note on Thursday, August 17th. Eleven analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Aetna has an average rating of “Buy” and an average target price of $170.34.

Shares of Aetna (NYSE:AET) traded up $2.59 during mid-day trading on Thursday, hitting $175.12. The stock had a trading volume of 2,240,977 shares, compared to its average volume of 3,100,742. Aetna has a 12 month low of $116.04 and a 12 month high of $184.98. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $56,262.04, a PE ratio of 16.90, a price-to-earnings-growth ratio of 1.57 and a beta of 0.61.

Aetna (NYSE:AET) last announced its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The business had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. During the same quarter in the prior year, the company earned $2.07 earnings per share. The company’s quarterly revenue was down 5.0% on a year-over-year basis. equities analysts forecast that Aetna will post 9.78 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://stocknewstimes.com/2017/11/11/cantor-fitzgerald-downgrades-aetna-inc-aet-to-neutral.html.

In other news, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the sale, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of AET. Bruderman Asset Management LLC acquired a new position in Aetna during the second quarter valued at $106,000. Lloyds Banking Group plc acquired a new position in Aetna during the third quarter valued at $106,000. Moisand Fitzgerald Tamayo LLC acquired a new position in Aetna during the third quarter valued at $116,000. Liberty Capital Management Inc. lifted its position in Aetna by 206.9% during the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after purchasing an additional 629 shares during the period. Finally, Guardian Life Insurance Co. of America lifted its position in Aetna by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after purchasing an additional 9 shares during the period. Institutional investors own 91.06% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply